Theravance Biopharma (TBPH) Earnings Date & Reports
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives... Show more
TBPH is expected to report earnings to fall 172.00% to 7 cents per share on August 05
Q2'26
Est.
$0.07
Q1'26
Missed
by $0.07
Q4'25
Beat
by $0.15
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.41
The last earnings report on May 07 showed earnings per share of -10 cents, missing the estimate of -2 cents. With 72.05K shares outstanding, the current market capitalization sits at 854.23M.